Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

Abstract Background Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders (PORs). Several studies showed that DHEA supplementation could improve IVF outcomes of PORs. However, most of the PORs do not respond to DHEA clinica...

Full description

Bibliographic Details
Main Authors: Chyi-Uei Chern, Kuan-Hao Tsui, Salvatore Giovanni Vitale, San-Nung Chen, Peng-Hui Wang, Antonio Cianci, Hsiao-Wen Tsai, Zhi-Hong Wen, Li-Te Lin
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Reproductive Biology and Endocrinology
Subjects:
Dehydroepiandrosterone
DHEA
Diminished ovarian reserve
In vitro fertilization
Poor ovarian responders
Online Access:http://link.springer.com/article/10.1186/s12958-018-0409-z

Internet

http://link.springer.com/article/10.1186/s12958-018-0409-z

Similar Items